Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Okayama Technology Licensing Organization (OTLO) is a specialized technology transfer company that facilitates the commercialization of research and intellectual property from Okayama University and other regional institutions in Japan. The organization serves as a vital intermediary between academic researchers and the industrial sector, focusing on patenting, marketing, and licensing innovative technologies. While its portfolio spans multiple disciplines, OTLO has a strong emphasis on life sciences, including drug discovery, medical devices, and regenerative medicine. By providing expert support in intellectual property management and business development, the company aims to transform academic breakthroughs into practical applications that benefit society and the economy. Notable successes include the licensing of gene therapy technologies and novel diagnostic markers for various oncology indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Okayama Technology Licensing Organization.